|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/10/21 Pharmagreen Biotech Inc. 10-K/A 9/30/20 3:1.1M Moroney Donna |
Document/Exhibit Description Pages Size 1: 10-K/A Pharmagreen Form 10-K/A HTML 286K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 8K 3: EX-32.1 Certification -- §906 - SOA'02 HTML 5K
| Exhibit 32.1 |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K/A for the period ended September 30, 2020, of Pharmagreen Biotech Inc, a Nevada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), we, Peter Wojcik, Principle Executive Officer of the Company and Terry Kwan, Principal Financial Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Annual Report fully complies with the requirements of Section 13(a) or15(d) of the Securities and Exchange Act of 1934, as amended; and
2. The information contained in this Annual Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
Date: June 9, 2021
/s/ Peter Wojcik
President and Director
Principal Executive Officer
/s/ Terry Kwan
Principal Accounting Officer
| This ‘10-K/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 6/10/21 | |||
| Filed on: | 6/9/21 | CORRESP | ||
| For Period end: | 9/30/20 | 10-K, NT 10-K | ||
| List all Filings | ||||